CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Hepatic CYP2E1 elevation with associated oxidative stress and consequently sustained JNK-activation has been implicated in NAFLD/NASH7, 8, 9, 10, 11, 30, 31, 32, 33, 34, 53, 54.